Search

Clinical Practice Guidelines

EHA creates clinical practice Guidelines for diagnosis and treatment of hematologic diseases. This initiative started in 2019 with the establishment of the EHA Guidelines Committee and the definition of the EHA Methodology for Guidelines.

Read more

Sponsor opportunities

The European Hematology Association (EHA) invites you to support the EHA-SWG Scientific Meeting on MDS/MPN/AML: Commonalities and differences of myeloid neoplasms.

Read more

Sponsorship Opportunities

The European Hematology Association (EHA) invites you to support the EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects: From Basic Science to Clinical Case Application.

Read more

International CML adherence survey launched

The drivers behind non-adherence, a highly prevalent problem in oral cancer treatments but also in many other diseases like diabetes, are not well understood to date.

Read more

Education Committee

Current committee members
Konstanze Döhner, Germany (Chair)
Kirsten Grønbæk, Denmark (Vice-Chair)
Meritxell Alberich Jordà, Czech Republic (Councilor)
Antonio Almeida, Portugal (EHA President)
Nuno Borges, United Kingdom (YoungEHA representative)
Gianluca Gaidano, Italy (Chair Community and Stakeholder Committee)
Jose Tomás Navarro Ferrando, Spain (Chair Curriculum-Exam Committee)
Anna Porwit, Sweden (EHA…

Read more

Position of EHA on Access to Medicines

 

There are many factors that compromise patient access to medicine. First and foremost, for a drug to be available, one has to be developed.

Read more

Position of EHA on Personalized Medicine

 

The challenge
Despite its apparent complexity, personalized medicine could transform healthcare, by tailoring healthcare solutions to the individual patient, delivering ‘the right treatment to the right patient at the right time’ – and helping to get more value from healthcare spending.…

Read more